Wegovy is an under-the-skin, self-administered injectable prescription medicine for patients with either: A body mass index (BMI) of 30 kg/m2 or greater A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others
You can choose to pay for your medication in cash or with commercial insurance
We do not promise specific timelines or outcomes
If you're considering other GLP-1 drugs for weight loss, our board-certified doctors can help support your weight management journey and see if one of these drugs is best for you
Lingvay receives personal consulting compensation from Novo Nordisk
As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly redesigning their menus offering customers scaled-down portions at lower prices, whether theyre on the drugs or not